Sinopharm Covid-19 Vaccine

Sinopharm Covid-19 Vaccine

A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang

Sinopharm needs trial results to decide if Covid-19 shot needs booster: Executive

"Antibodies triggered by two Covid-19 vaccine products from Sinopharm both have good neutralising effect on variants found in Britain and South Africa"

A sign of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang

Sinopharm's Wuhan unit reports 72.5% efficacy for Covid shot, seeks approval in China

A sign of Sinopharm is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the COVID-19 outbreak, in Beijing, China September 5, 2020. REUTERS/Tingshu Wang

Senegal begins vaccinating against coronavirus with doses from China

FILE PHOTO: The company logo of Sinopharm Group Co Ltd is displayed at a news conference on the company's annual results in Hong Kong, China March 29, 2016. REUTERS/Bobby Yip/File Photo

Hungary to receive 500,000 doses of Chinese Sinopharm's vaccine - PM's chief of staff